Medical cannabis

A dried bud of cannabis, which can be used for medical therapy.

Medical cannabis, or medical marijuana, refers to the use of [2]

The

  • Medical cannabis at DMOZ, links to websites about medical cannabis
  • Information on Cannabis and Cannabinoids from the U.S. National Cancer Institute
  • Information on cannabis (marihuana, marijuana) and the cannabinoids from Health Canada
  • The Center for Medicinal Cannabis Research of the University of California

External links

  • 2009 Conference on Cannabinoids in Medicine, International Association for Cannabis as Medicine

Further reading

  1. ^
  2. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z
  3. ^ a b c d e f g
  4. ^ a b c
  5. ^ a b c d e f
  6. ^
  7. ^
  8. ^ a b
  9. ^
  10. ^
  11. ^
  12. ^
  13. ^
  14. ^
  15. ^
  16. ^
  17. ^ a b
  18. ^
  19. ^
  20. ^
  21. ^
  22. ^
  23. ^ a b
  24. ^ a b
  25. ^
  26. ^
  27. ^
  28. ^
  29. ^
  30. ^ a b
  31. ^
  32. ^ a b
  33. ^
  34. ^ a b c d e f g h i j
  35. ^ a b
  36. ^ a b
  37. ^
  38. ^ a b c
  39. ^
  40. ^
  41. ^
  42. ^
  43. ^ a b c
  44. ^
  45. ^
  46. ^
  47. ^ a b
  48. ^
  49. ^
  50. ^
  51. ^
  52. ^
  53. ^
  54. ^
  55. ^
  56. ^
  57. ^ a b
  58. ^
  59. ^
  60. ^ a b c d
  61. ^
  62. ^ Li, Hui-Lin (1974). "An Archaeological and Historical Account of Cannabis in China", Economic Botany 28.4:437–448, p. 444.
  63. ^
  64. ^
  65. ^
  66. ^
  67. ^
  68. ^ a b
  69. ^
  70. ^
  71. ^ Dr Farid F. Youssef. "Cannibis Unmasked: What it is and why it does what it does". UWIToday: June 2010. http://sta.uwi.edu/uwitoday/archive/june_2010/article9.asp
  72. ^
  73. ^
  74. ^ a b
  75. ^
  76. ^ a b
  77. ^
  78. ^
  79. ^ http://techcrunch.com/2014/10/14/uber-for-weed-startup-meadow-lights-up-in-san-francisco/
  80. ^
  81. ^
  82. ^ a b
  83. ^
  84. ^
  85. ^
  86. ^
  87. ^
  88. ^
  89. ^ a b
  90. ^
  91. ^
  92. ^ a b
  93. ^
  94. ^
  95. ^
  96. ^
  97. ^ a b
  98. ^
  99. ^
  100. ^
  101. ^
  102. ^
  103. ^
  104. ^
  105. ^
  106. ^
  107. ^
  108. ^
  109. ^
  110. ^
  111. ^
  112. ^
  113. ^
  114. ^

References

See also

Cannabinoid medication might be useful in the treatment of the symptoms in patients with TS,[34] but the 2009 review found that the two relevant studies of cannibinoids in treating tics had attrition bias, and that there was "not enough evidence to support the use of cannabinoids in treating tics and obsessive compulsive behaviour in people with Tourette's syndrome".[34]

A 2009 Cochrane review examined the two controlled trials to date using cannabinoids of any preparation type for the treatment of tics or TS (Muller-Vahl 2002, and Muller-Vahl 2003). Both trials compared delta-9-THC; 28 patients were included in the two studies (8 individuals participated in both studies).[34] Both studies reported a positive effect on tics, but "the improvements in tic frequency and severity were small and were only detected by some of the outcome measures".[34] The sample size was small and a high number of individuals either dropped out of the study or were excluded.[34] The original Muller-Vahl studies reported individuals who remained in the study; patients may drop out when adverse effects are too high or efficacy is not evident.[34] The authors of the original studies acknowledged few significant results after Bonferroni correction.[34]

A 2007 review of the history of medical cannabis said cannabinoids showed potential therapeutic value in treating Tourette syndrome (TS).[112] A 2005 review said that controlled research on treating TS with dronabinol showed the patients taking the pill had a beneficial response without serious adverse effects;[113] a 2000 review said other studies had shown that cannabis "has no effects on tics and increases the individuals inner tension".[114]

Tourette syndrome

In 2009, the American Glaucoma Society noted that while cannabis can help lower intraocular pressure, it recommended against its use because of "its side effects and short duration of action, coupled with a lack of evidence that its use alters the course of glaucoma".[110] As of 2008 relatively little research had been done concerning therapeutic effects of cannabinoids on the eyes.[111]

Glaucoma

A 2012 Cochrane review said there is not enough evidence to draw conclusions about the safety or efficacy of cannabinoids in the treatment of epilepsy.[104] As of 2012, there have been few studies of the anticonvulsive properties of CBD and epileptic disorders. The major reasons for the lack of clinical research have been the introduction of new synthetic and more stable pharmaceutical anticonvulsants, the recognition of important adverse effects and the legal restriction to the use of cannabis-derived medicines.[105] Epidiolex, a cannabis-based product developed by GW Pharmaceuticals for experimental treatment of epilepsy, underwent stage-two trials in the US in 2014.[106] Pairs of phase 3 trials for Dravet syndrome and Lennox-Gastaut syndrome have begun and should be completed in 2015.[107][108] They are also running a phase 2 study of non-psychoactive cannabidivarin.[109]

Epilepsy

There is emerging evidence that cannabidiol may help slow cell damage in diabetes mellitus type 1.[101] There is a lack of meaningful evidence of the effects of medical cannabis use on people with diabetes; a 2010 review concluded that "the potential risks and benefits for diabetic patients remain unquantified at the present time".[102] GW is studying tetrahydrocannabivarin for type 2 diabetes.[103]

Diabetes

Cannabinoids have been proposed to have the potential for lessening the effects of Alzheimer's disease.[98] A 2012 review of the effect of cannabinoids on brain ageing found that "clinical evidence regarding their efficacy as therapeutic tools is either inconclusive or still missing".[99] A 2009 Cochrane review said that the "one small randomized controlled trial [that] assessed the efficacy of cannabinoids in the treatment of dementia ... [had] ... poorly presented results and did not provide sufficient data to draw any useful conclusions".[100]

Dementia

There is no firm evidence that cannabis helps reduce the risk of getting cancer; whether it increases the risk is difficult to establish, since most users smoke it mixed with tobacco, and this complicates research.[97]

Cannabinoids have been shown to exhibit some anti-cancer effects in laboratory experiments, although there has been little research into their use as a cancer treatment in people.[94] Laboratory experiments have suggested that cannabis and cannabinoids have anticarcinogenic and antitumor effects,[95] including a potential effect on breast- and lung-cancer cells.[89] The National Cancer Institute reports that as of November 2013 there have been no clinical trials on the use of cannabis to treat cancer in people, and only one small study using delta-9-THC that reported potential antitumoral activity.[96] Although there is ongoing research, claims that cannabis has been proved to cure cancer are, according to Cancer Research UK, both prevalent on the internet and "highly misleading".[97]

Cancer

A 2007 review said cannabidiol had shown potential to relieve convulsion, inflammation, cough, congestion and nausea, and to inhibit cancer cell growth.[92] Preliminary studies have also shown potential over psychiatric conditions such as anxiety, depression, and psychosis.[93] Because cannabidiol relieves the aforementioned symptoms, cannabis strains with a high amount of CBD may benefit people with multiple sclerosis or frequent anxiety attacks.[30][92]

Cannabis is being investigated for its possible use in inflammatory bowel disease but as of 2014 there is only weak evidence for its benefits as a treatment.[91]

In 2014, the American Academy of Neurology reviewed all available findings levering the use of marijuana to treat brain diseases. The result was that the scientific evidence is weak that cannabis in any form serves as medicinal for curing or alleviating neurological disorders. To ease multiple sclerosis patients' stiffness, which may be accomplished by their taking cannabis extract by mouth or as a spray, there is support. The academy has published new guidelines on the use of marijuana pills and sprays in the treatment of MS.[90]

Cannabinoids have been proposed for the treatment of primary anorexia nervosa, but have no measurable beneficial effect.[87] The authors of a 2003 paper argued that cannabinoids might have useful future clinical applications in treating digestive diseases.[88] Laboratory experiments have shown that cannabinoids found in marijuana may have analgesic and anti-inflammatory effects.[89]

A 2005 review and meta-analysis said that bipolar disorder was not well-controlled by existing medications and that there were "good pharmacological reasons" for thinking cannabis had therapeutic potential, making it a good candidate for further study.[86]

Anecdotal evidence and pre-clinical research has suggested that cannabis or cannabinoids may be beneficial for treating Huntington's disease or Parkinson's disease, but follow-up studies of people with these conditions have not produced good evidence of therapeutic potential.[84] A 2001 paper argued that cannabis had properties that made it potentially applicable to the treatment of amyotrophic lateral sclerosis, and on that basis research on this topic should be permitted, despite the legal difficulties of the time.[85]

The Schedule I classification of cannabis in the US makes the study of medical cannabis difficult.[2]

"Victoria", the United States' first legal medical marijuana plant grown by The Wo/Men's Alliance for Medical Marijuana.

Research

Relative to inhaled consumption, peak concentration of oral THC is delayed, and it may be difficult to determine optimal dosage because of variability in patient aborption.[2]

[2] It is also approved in several European countries for overactive bladder and vomiting.[60] When sold under the trade name Sativex as a mouth spray, the prescribed daily dose in Sweden delivers a maximum of 32.4 mg of THC and 30 mg of CBD; mild to moderate dizziness is common during the first few weeks.[83]

As an [2]

Generic
medication
Brand
name(s)
Country Licensed indications
Nabilone Cesamet U.S., Canada [2]
Dronabinol Marinol U.S., Canada [2]
U.S. Anorexia associated with AIDS–related weight loss[2]
Nabiximols Sativex Canada, New Zealand,
eight European countries
as of 2013
Limited treatment for spasticity and neuropathic pain associated with [2]

In the U.S., the FDA has approved two oral cannabinoids for use as medicine: [2]

Brand names

The authors of a report on a 2011 survey of medical cannabis users say that critics have suggested that some users "game the system" to obtain medical cannabis ostensibly for treatment of a condition, but then use it for nonmedical purposes – though the truth of this claim is hard to measure.[82] The report authors suggested rather that medical cannabis users occupied a "continuum" between medical and nonmedical use.[82]

Recreational use

In the United States, health insurance companies may not pay for a medical marijuana prescription as the Food and Drug Administration must approve any substance for medicinal purposes. Before this can happen, the FDA must first permit the study of the medical benefits and drawbacks of the substance, which it has not done since it was placed on Schedule I of the Controlled Substances Act in 1970. Therefore, all expenses incurred fulfilling a medical marijuana prescription will possibly be incurred as out-of-pocket.[80] However, the New Mexico Court of Appeals has ruled that workers' compensation insurance must pay for marijuana prescribed as part of the state's Medical Cannabis Program.[81]

Insurance

The method of obtaining medical cannabis varies by region and by legislation. In the US, most consumers grow their own or buy it from dispensaries in the 23 states and the District of Columbia that permit the use of medical cannabis.[2][77] Marijuana vending machines for selling or dispensing cannabis are in use in the United States and are planned to be used in Canada.[78] In 2014, the startup Meadow began offering on-demand delivery of medical marijuana in the San Francisco Bay Area, through their mobile app.[79]

Medical marijuana dispensary

Distribution

Economics

As of 2014, 23 states plus the District of Columbia have passed medical cannabis laws,[74] but its use remains illegal by federal law.[32] In 1978 the US government created a program called the Compassionate Investigational New Drug program which dispenses cannabis cigarettes to 20 people with debilitating conditions[5] including glaucoma and a rare bone disease. The program was "closed to new candidates in 1991",[5] but as of 2013, allowed four people previously in the program to continue receiving medical cannabis.

Programs

The convention thus allows countries to outlaw cannabis for all non-research purposes but lets nations choose to allow medical and scientific purposes if they believe total prohibition is not the most appropriate means of protecting health and welfare. The convention requires that states that permit the production or use of medical cannabis must operate a licensing system for all cultivators, manufacturers and distributors and ensure that the total cannabis market of the state shall not exceed that required "for medical and scientific purposes."[76]

A Party shall, if in its opinion the prevailing conditions in its country render it the most appropriate means of protecting the public health and welfare, prohibit the production, manufacture, export and import of, trade in, possession or use of any such drug except for amounts which may be necessary for medical and scientific research only, including clinical trials therewith to be conducted under or subject to the direct supervision and control of the Party.

Cannabis is in Schedule IV of the United Nations' Single Convention on Narcotic Drugs, making it subject to special restrictions. Article 2 provides for the following, in reference to Schedule IV drugs:[76]

Medical use of cannabis or preparation containing THC as the active substance is legalized in Austria, Belgium, Canada, Czech Republic, Finland, Israel, Netherlands, Spain, the UK and some states in the US, although it is illegal under US federal law.

Worldwide laws on cannabis possession for medical purposes as of 2014

Legal status

Society and culture

On June 15, 2015, the Colorado Supreme Court ruled that even though medical marijuana is legal in Colorado, employers can fire workers who use marijuana for medical reasons because it violates federal law. The case involved a quadriplegic who had a doctor’s authorization to smoke medical marijuana, but who was fired by Dish Network in 2010 after failing a company drug test.[75]

Voters in eight US states showed their support for cannabis prescriptions or recommendations given by physicians between 1996 and 1999, going against policies of the federal government.[73] As of mid-2014, 23 states plus the District of Columbia have passed medical marijuana laws,[74] and in the November elections three more states (total 26) joined the burgeoning group, many of which are as yet in conflict with conditions set forth by the federal government.

In the 1970s, a synthetic version of THC was produced and approved for use in the United States as the drug Marinol.[72]

Albert Lockhart and Manley West began studying in 1964 the health effects of traditional cannabis use in Jamaican communities. They developed, and in 1987 gained permission to market, the pharmaceutical "Canasol", one of the first cannabis extracts.[71]

An Irish physician, William Brooke O'Shaughnessy, is credited with introducing the therapeutic use of cannabis to Western medicine, to help treat muscle spasms, stomach cramps and general pain.[70]

Modern

In the medieval Islamic world, Arabic physicians made use of the diuretic, antiemetic, antiepileptic, anti-inflammatory, analgesic and antipyretic properties of Cannabis sativa, and used it extensively as medication from the 8th to 18th centuries.[69]

The Ancient Greeks used cannabis to dress wounds and sores on their horses,[68] and in humans, dried leaves of cannabis were used to treat nose bleeds, and cannabis seeds were used to expel tapeworms.[68]

Surviving texts from ancient India confirm that cannabis' psychoactive properties were recognized, and doctors used it for treating a variety of illnesses and ailments, including insomnia, headaches, gastrointestinal disorders, and pain, including during childbirth.[67]

The Ebers Papyrus (ca. 1550 BCE) from Ancient Egypt describes medical cannabis.[65] The ancient Egyptians used hemp (cannabis) in suppositories for relieving the pain of hemorrhoids.[66]

Cannabis, called 麻 (meaning "hemp; cannabis; numbness") or dàmá 大麻 (with "big; great") in Chinese, was used in Taiwan for fiber starting about 10,000 years ago.[61] The botanist Li Hui-Lin wrote that in China, "The use of Cannabis in medicine was probably a very early development. Since ancient humans used hemp seed as food, it was quite natural for them to also discover the medicinal properties of the plant."[62] Emperor Shen-Nung, who was also a pharmacologist, wrote a book on treatment methods in 2737 BCE that included the medical benefits of cannabis. He recommended the substance for many ailments, including constipation, gout, rheumatism, and absent-mindedness.[63] Cannabis is one of the 50 "fundamental" herbs in traditional Chinese medicine.[64]

Ancient

History

The most psychoactive cannabinoid found in the cannabis plant is tetrahydrocannabinol (or delta-9-tetrahydrocannabinol, commonly known as THC).[5] Other cannabinoids include delta-8-tetrahydrocannabinol, cannabidiol (CBD), cannabinol (CBN), cannabicyclol (CBL), cannabichromene (CBC) and cannabigerol (CBG); they have less psychotropic effects than THC, but may play a role in the overall effect of cannabis.[5] The most studied are THC, CBD and CBN.[57]

The [2] As of 2012, more than 20 cannabinoids were being studied by the U.S. FDA.[60]

Pharmacology

A 2013 literature review found that exposure to marijuana had biologically-based physical, mental, behavioral and social health consequences and was "associated with diseases of the liver (particularly with co-existing hepatitis C), lungs, heart, and vasculature".[57]

Cannabis usually causes no tolerance or withdrawal symptoms except in heavy users. In a survey of heavy users 42.4% experienced withdrawal symptoms when they tried to quit marijuana such as craving, irritability, boredom, anxiety and sleep disturbances.[55] About 9% of those who experiment with marijuana eventually become dependent. The rate goes up to 1 in 6 among those who begin use as adolescents, and one quarter to one-half of those who use it daily according to a [2] The highest risk of cannabis dependence is found in those with a history of poor academic achievement, deviant behavior in childhood and adolescence, rebelliousness, poor parental relationships, or a parental history of drug and alcohol problems.[56]

There is serious suspicion among cardiologists, spurring research but falling short of definitive proof, that cannabis use has the potential to contribute to cardiovascular disease.[51] Cannabis is believed to be an aggravating factor in rare cases of arteritis, a serious condition that in some cases leads to amputation. Because 97% of case-reports also smoked tobacco, a formal association with cannabis could not be made. If cannabis arteritis turns out to be a distinct clinical entity, it might be the consequence of vasoconstrictor activity observed from delta-8-THC and delta-9-THC.[52] Other serious cardiovascular events including myocardial infarction, stroke, sudden cardiac death, and cardiomyopathy have been reported to be temporally associated with cannabis use. Research in these events is complicated because cannabis is often used in conjunction with tobacco, and drugs such as alcohol and cocaine.[53] These putative effects can be taken in context of a wide range of cardiovascular phenomena regulated by the endocannabinoid system and an overall role of cannabis in causing decreased peripheral resistance and increased cardiac output, which potentially could pose a threat to those with cardiovascular disease.[54]

Cannabis smoke contains thousands of organic and inorganic chemical compounds. This tar is chemically similar to that found in tobacco smoke,[48] and over fifty known carcinogens have been identified in cannabis smoke,[49] including; nitrosamines, reactive aldehydes, and polycylic hydrocarbons, including benz[a]pyrene.[50] Light and moderate use of cannabis is not believed to increase risk of lung or upper airway cancer. Evidence for causing these cancers is mixed concerning heavy, long-term use. In general there are far lower risks of pulmonary complications for regular cannabis smokers when compared with those of tobacco.[47] Combustion products are not present when using a vaporizer, consuming THC in pill form, or consuming cannabis foods.

There has been a limited amount of studies that have looked at the effects of smoking cannabis on the respiratory system.[46] Chronic heavy marijuana smoking is associated with coughing, production of sputum, wheezing, coughing, and other symptoms of chronic bronchitis.[38] Regular cannabis use has not been shown to cause significant abnormalities in lung function.[47]

Effects of chronic use may include bronchitis, a cannabis dependence syndrome, and subtle impairments of attention and memory. These deficits persist while chronically intoxicated.[38] There is little evidence that cognitive impairments persist in adult abstinent cannabis users.[44] Compared to non-smokers, people who smoked cannabis regularly in adolescence exhibit reduced connectivity in specific brain regions associated with memory, learning, alertness, and executive function.[43] A study has suggested that sustained heavy, daily, adolescent onset cannabis use over decades is associated with a decline in IQ by age 38. No effects were found in those who initiated cannabis use later, or in those who ceased use earlier in adulthood.[45]

According to the United States Department of Health and Human Services, there were 455,000 emergency room visits associated with cannabis use in 2011. These statistics include visits in which the patient was treated for a condition induced by or related to recent cannabis use. The drug use must be "implicated" in the emergency department visit, but does not need to be the direct cause of the visit. Most of the illicit drug emergency room visits involved multiple drugs.[41] In 129,000 cases, cannabis was the only implicated drug.[42][43]

THC, the principal psychoactive constituent of the cannabis plant, has low toxicity, the LD50 (dose of THC needed to kill 50% of tested rodents) is extremely high. Acute effects may include anxiety and panic, impaired attention, and memory (while intoxicated), an increased risk of psychotic symptoms, and possibly and increased risk of accidents if a person drives a motor vehicle while intoxicated.[38] Psychotic episodes are well-documented and typically resolve within minutes or hours. There have been few reports of symptoms lasting longer.[39][40]

Recreational use

There is insufficient data to draw strong conclusions about the safety of medical cannabis.[36] Typically, adverse effects of medical cannabis use are not serious.[2] These include: tiredness, dizziness, cardiovascular and psychoactive effects. Tolerance to these effects develops over a period of days or weeks. The amount of cannabis normally used for medicinal purposes is not believed to cause any permanent cognitive impairment in adults, though long-term treatment in adolescents should be weighed carefully as they are more susceptible to these impairments. Withdrawal symptoms are rarely a problem with controlled medical administration of cannabinoids. The ability to drive vehicle or operating machinery may be impaired until a tolerance is developed.[17] Although supporters of medical cannabis say that it is safe,[36] further research is required to assess the long-term safety of its use.[4][37]

Medical use

Adverse effects

The U.S. Food and Drug Administration (FDA) has not approved smoked cannabis for any condition or disease as it deems evidence is lacking concerning safety and efficacy of cannabis for medical use.[35] The FDA issued a 2006 advisory against smoked medical cannabis stating: "marijuana has a high potential for abuse, has no currently accepted medical use in treatment in the United States, and has a lack of accepted safety for use under medical supervision."[35]

Cannabinoid medicines are available in pill form ([2] Oral preparations are "problematic due to the uptake of cannabinoids into fatty tissue, from which they are released slowly, and the significant first-pass liver metabolism, which breaks down Δ9THC and contributes further to the variability of plasma concentrations".[34]

[2]

Smoking is the means of administration of cannabis for many consumers,[34] and the most common method of medical cannabis consumption in the US as of 2013.[2] It is difficult to predict the pharmacological response to cannabis because concentration of cannabinoids varies widely as there are different ways of preparing cannabis for consumption (smoked, applied as oils, eaten, infused into other foods, or drunk) and a lack of production controls.[2] The potential for adverse effects from smoke inhalation makes smoking a less viable option than oral preparations.[34]

Some forms of medicinal cannabis.

Available forms

The efficacy of cannabis in treating neurological problems, including multiple sclerosis, epilepsy, and movement problems, is not clear.[29] Studies of the efficacy of cannabis for treating multiple sclerosis have produced varying results. The combination of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extracts give subjective relief of spasticity, though objective post-treatment assessments do not reveal significant changes.[30] Evidence also suggests that oral cannabis extract is effective for reducing patient-centered measures of spasticity.[31] A trial of cannabis is deemed to be a reasonable option if other treatments have not been effective.[2] Its use for MS is approved in ten countries.[2][32] A 2012 review found no problems with tolerance, abuse or addiction.[33]

Neurological problems

Cannabis appears to be somewhat effective for the treatment of chronic pain, including pain caused by neuropathy and possibly that due to fibromyalgia and rheumatoid arthritis.[23][24] A 2009 review states it was unclear if the benefits were greater than the risks,[23] while a 2011 review considered it generally safe for this use.[24] In palliative care the use appears safer than that of opioids.[25] A 2014 review found limited and weak evidence that smoked cannabis was effective for chronic non-cancer pain. The review recommended that it be used for people for whom cannabinoids and other analgesics were not effective.[26] A 2015 review found moderate quality evidence that cannabinoids were effective for chronic pain.[3] A 2015 meta-analysis found that inhaled medical cannabis was effective in reducing neuropathic pain in the short term for one in five to six patients.[27] Another 2015 systematic review and meta-analysis found limited evidence that medical cannabis was effective for neuropathic pain when combined with traditional analgesics.[28]

Pain

Evidence is lacking for both efficacy and safety of cannabis and cannabinoids in treating patients with HIV/AIDS or for anorexia associated with AIDS. As of 2013, current studies suffer from effects of bias, small sample size, and lack of long-term data.[22]

HIV/AIDS

A 2010 Cochrane review said that cannabinoids were "probably effective" in treating chemotherapy-induced nausea in children, but with a high side effect profile (mainly drowsiness, dizziness, altered moods, and increased appetite). Less common side effects were "occular problems, orthostatic hypotension, muscle twitching, pruritis, vagueness, hallucinations, lightheadedness and dry mouth".[21]

Medical cannabis is somewhat effective in [2] and may be a reasonable option in those who do not improve following preferential treatment.[17] Comparative studies have found cannabinoids to be more effective than some conventional antiemetics such as prochlorperazine, promethazine, and metoclopramide in controlling CINV,[18] but these are used less frequently because of side effects including dizziness, dysphoria, and hallucinations.[4][19] Long-term cannabis use may cause nausea and vomiting, a condition known as cannabinoid hyperemesis syndrome.[20]

Nausea and vomiting

The [15] It is recommended that cannabis use be stopped in pregnancy.[16]

Medical cannabis has several potential beneficial effects.[3] Evidence is moderate that it helps in chronic pain and muscles spasms.[3] Lesser evidence supports its use to help with nausea during chemotherapy, improve appetite in those with HIV/AIDS, help with sleep, and help with Tourettes syndrome.[3]

Cannabis as illustrated in Köhler's book of medicinal plants from 1897

Medical uses

Contents

  • Medical uses 1
    • Nausea and vomiting 1.1
    • HIV/AIDS 1.2
    • Pain 1.3
    • Neurological problems 1.4
    • Available forms 1.5
  • Adverse effects 2
    • Medical use 2.1
    • Recreational use 2.2
  • Pharmacology 3
  • History 4
    • Ancient 4.1
    • Modern 4.2
  • Society and culture 5
    • Legal status 5.1
      • Programs 5.1.1
    • Economics 5.2
      • Distribution 5.2.1
      • Insurance 5.2.2
    • Recreational use 5.3
    • Brand names 5.4
  • Research 6
    • Cancer 6.1
    • Dementia 6.2
    • Diabetes 6.3
    • Epilepsy 6.4
    • Glaucoma 6.5
    • Tourette syndrome 6.6
  • See also 7
  • References 8
  • Further reading 9
  • External links 10

Medical cannabis can be administered using a variety of methods, including vaporizing or smoking dried buds, eating extracts, taking capsules or using oral sprays. Synthetic cannabinoids are available as prescription drugs in some countries; examples include: dronabinol and nabilone. Recreational use of cannabis is illegal in most parts of the world, but the medical use of cannabis is legal in certain countries, including Austria, Canada, Czech Republic, Finland, Germany, Israel, Italy, the Netherlands, Portugal and Spain. Australia is currently in the process of passing a law which would allow the use of marijuana for medical and scientific purposes.[11][12] In the United States, federal law outlaws all cannabis use, while 20 states and the District of Columbia no longer prosecute individuals for the possession or sale of marijuana, as long as the individuals are in compliance with the state's marijuana sale regulations. However, an appeals court ruled in January 2014 that a 2007 Ninth Circuit ruling remains binding in relation to the ongoing illegality, in federal legislative terms, of Californian cannabis dispensaries, reaffirming the impact of the federal Controlled Substances Act.[13]

[10][9][8] to facilitate this research.DEA Schedule I states that while cannabinoids may have potential as therapy for a number of medical conditions, they do not recommend it until more research is done. They, along with the American Medical Association and the Minnesota Medical Association, call for moving cannabis out of American Academy of Pediatrics The [8][7][6]